会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Compositions for, and methods of, treating atherosclerosis
    • 治疗动脉粥样硬化的组合物和方法
    • US20040220392A1
    • 2004-11-04
    • US10770969
    • 2004-05-06
    • Leo J. Romanczyk, JR.Harold H. Schmitz
    • C07H017/00C07D311/74
    • C07H17/06A23G1/32A23G3/36A23K20/111A23K50/40A61K9/2018A61K9/2068A61K9/4858A61K31/353A61K31/7048A61K36/185A61K45/06C07D311/32C07D311/62C07D311/64C11B5/0035A61K2300/00
    • Disclosed and claimed are cocoa extracts, compounds, combinations thereof and compositions containing the same, such as polyphenols or procyanidins, methods for preparing such extracts, compounds and compositions, as well as uses for them, especially a polymeric compound of the formula An, wherein A is a monomer of the formula: 1 wherein n is an integer from 2 to 18, such that there is at least one terminal monomeric unit A, and one or a plurality of additional monomeric units; R is 3-(null)-OH, 3-(null)-OH, 3-(null)-o-sugar, or 3-(null)-O-sugar; bonding between adjacent monomers takes place at positions 4, 6 or 8; a bond of an additional monomeric unit in position 4 has alpha or beta stereochemistry; X, Y and Z are selected from the group consisting of monomeric unit A, hydrogen, and a sugar, with the provisos that as to the at least one terminal monomeric unit, bonding of the additional monomeric unit thereto (the bonding of the additional monomeric unit adjacent to the terminal monomeric unit) is at position 4 and optionally YnullZnullhydrogen; the sugar is optionally substituted with a phenolic moiety, at any position on the sugar, for instance via an ester bond, and pharmaceutically acceptable salts or derivatives thereof (including oxidation products).
    • 公开和要求保护的是可可提取物,化合物,其组合和含有它们的组合物,例如多酚或原花青素,制备此类提取物,化合物和组合物的方法,以及它们的用途,特别是式An的聚合化合物,其中 A是下式的单体:其中n是2至18的整数,使得存在至少一个末端单体单元A和一个或多个另外的单体单元; R是3-(α)-OH,3-(β)-OH,3-(α) - 糖或3-(β)-O-糖; 相邻单体之间的结合发生在位置4,6或8; 位置4的附加单体单元的键具有α或β立体化学; X,Y和Z选自单体单元A,氢和糖,条件是对于至少一个末端单体单元,附加单体单元与其结合(附加单体单元的键合 邻近末端单体单元的单元)在位置4且任选地Y = Z =氢; 糖任选被酚部分取代,在糖上的任何位置,例如通过酯键,及其药学上可接受的盐或衍生物(包括氧化产物)。
    • 7. 发明授权
    • Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
    • 在压片组合物和胶囊填充组合物中使用具有高可可多元酚含量的可可固体
    • US06297273B1
    • 2001-10-02
    • US08831245
    • 1997-04-02
    • Leo J. Romanczyk, Jr.
    • Leo J. Romanczyk, Jr.
    • A61K920
    • C07H17/06A23G1/32A23G3/36A23K20/111A23K50/40A61K9/2018A61K9/2068A61K9/4858A61K31/353A61K31/7048A61K36/185A61K45/06C07D311/32C07D311/62C07D311/64C11B5/0035A61K2300/00
    • Disclosed and claimed are cocoa extracts, compounds, combinations thereof and compositions containing the same, such as polyphenols or procyanidins, methods for preparing such extracts, compounds and compositions, as well as uses for them, especially a polymeric compound of the formula An, wherein A is a monomer of the formula: wherein n is an integer from 2 to 18, such that there is at least one terminal monomeric unit A, and one or a plurality of additional monomeric units; R is 3-(&agr;)-OH, 3-(&bgr;)-OH, 3-(&agr;)-O-sugar, or 3-(&bgr;)-O-sugar; bonding between adjacent monomers takes place at positions 4, 6 or 8; a bond of an additional monomeric unit in position 4 has alpha or beta stereochemistry; X, Y and Z are selected from the group consisting of monomeric unit A, hydrogen, and a sugar, with the provisos that as to the at least one terminal monomeric unit, bonding of the additional monomeric unit thereto (the bonding of the additional monomeric unit adjacent to the terminal monomeric unit) is at position 4 and optionally Y=Z=hydrogen; the sugar is optionally substituted with a phenolic moiety, at any position on the sugar, for instance via an ester bond, and pharmaceutically acceptable salts or derivatives thereof (including oxidation products).
    • 公开和要求保护的是可可提取物,化合物,其组合和含有它们的组合物,例如多酚或原花青素,制备此类提取物,化合物和组合物的方法,以及它们的用途,特别是式An的聚合化合物,其中 A是下式的单体:其中n是2至18的整数,使得存在至少一个末端单体单元A和一个或多个另外的单体单元; R是3-(α)-OH, 3-(β)-OH,3-(α)-O-糖或3-(β)-O-糖;相邻单体之间的键合发生在位置4,6或8;附加单体单元的键 位置4具有α或β立体化学; X,Y和Z选自单体单元A,氢和糖,条件是对于至少一个末端单体单元,附加单体单元 单元(其中附加的单体单元与末端单体相邻) 单元)位于第4位并且任选地Y = Z =氢;糖任选被酚部分取代,在糖上的任何位置,例如通过酯键,以及其药学上可接受的盐或其衍生物(包括氧化产物)。